100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide
● In Stock
| Catalogue No.: | VE0011029 |
|---|---|
| CAS No.: | N/A |
| Mol. Formula: | C14H21N3O |
| Mol. Weight: | 247.34 g/mol |
Additional information on N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amide
Parent drug
TofacitinibIUPAC Name
N-(1-benzyl-4-methylpiperidin-3-yl)-N-methylnitrous amideSynonyms
7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1 (phenylMethyl)-3-piperidinyl]- CHEMBL2152298Description
Request a Quote
"*" indicates required fields
Other products related to Tofacitinib impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
![3-(4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](https://veeprho.com/wp-content/uploads/2022/08/3-4-methyl-3-methyl-7-nitroso-7H-pyrrolo-2-3-d-pyrimidin-4-yl-amino-piperidin-1-yl-3-oxopropanenitri.png "3-(4-methyl-3-(methyl(7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile")
Tofacitinib
CAS No. N/A
Cat No. VE009894
![N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-amine](https://veeprho.com/wp-content/uploads/2023/02/N-methyl-N-3S-4S-4-methyl-1-nitrosopiperidin-3-yl-7-nitroso-7H-pyrrolo-2-3-d-pyrimidin-4-amine.png "N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-7-nitroso-7H-pyrrolo[2,3-d]pyrimidin-4-amine")
Tofacitinib
CAS No. N/A
Cat No. VE0011035
![N-methyl-N-(3R,4R)-(4-methyl-1-nitrosopiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine](https://veeprho.com/N-methyl-N-4-methyl-1-nitrosopiperidin-3-yl-7H-pyrrolo23-dpyrimidin-4-amine.jpeg "N-methyl-N-(3R,4R)-(4-methyl-1-nitrosopiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine")
Tofacitinib
CAS No. N/A
Cat No. VE009895
![Ethyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate](https://veeprho.com/wp-content/uploads/2022/11/Ethyl-4-cyano-3-imino-5-3R-4R-4-methyl-3-methyl-7H-pyrrolo-2-3-d-pyrimidin-4-yl-amino-piperidin-1-yl-5-oxopentanoate.png "Ethyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate")
Tofacitinib
CAS No. 2102039-99-4
Cat No. VE0010253
Tofacitinib
CAS No. N/A
Cat No. VE0010540
![Butyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate](https://veeprho.com/wp-content/uploads/2022/11/Butyl-4-cyano-3-imino-5-3R-4R-4-methyl-3-methyl-7H-pyrrolo-2-3-d-pyrimidin-4-yl-amino-piperidin-1-yl-5-oxopentanoate.png "Butyl 4-cyano-3-imino-5-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-5-oxopentanoate")
Tofacitinib
CAS No. N/A
Cat No. VE0010254
![N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-7-nitroso-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine](https://veeprho.com/wp-content/uploads/2023/02/N-methyl-N-3S-4S-4-methyl-1-nitrosopiperidin-3-yl-7-nitroso-6-7-dihydro-5H-pyrrolo-2-3-d-pyrimidin-4-amine.png "N-methyl-N-((3S,4S)-4-methyl-1-nitrosopiperidin-3-yl)-7-nitroso-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidin-4-amine")
Tofacitinib
CAS No. N/A
Cat No. VE0011036